OKYO Pharma Limited (OKYO)

NASDAQ: OKYO · Real-Time Price · USD

2.170

+0.220 (11.28%)

At close: Feb 12, 2026, 4:00 PM EST

1.930

-0.240 (-11.06%)

After-hours: Feb 12, 2026, 6:12 PM EST

OKYO Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 12, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	88	43	50	34	109	74
Market Cap Growth	151.05%	-12.97%	47.06%	-68.99%	46.71%	1100.45%
Enterprise Value	77	42	48	33	103	67
Last Close Price	1.95	1.27	1.49	1.32	5.14	7.15
PB Ratio	-	-7.77	-8.42	-16.40	36.84	13.94
P/TBV Ratio	-	-	-	-	36.84	13.94
Debt / Equity Ratio	-0.05	-	-	-1.08	-	0.02
Net Debt / Equity Ratio	1.18	0.28	0.14	0.89	-0.92	-1.28
Net Debt / EBITDA Ratio	0.65	0.22	0.05	0.14	0.44	2.01
Net Debt / FCF Ratio	1.30	0.86	0.09	0.24	0.49	4.22
Quick Ratio	0.53	0.37	0.19	0.69	2.65	4.08
Current Ratio	0.58	0.40	0.21	0.72	3.17	4.09
Return on Equity (ROE)	-	-	-	-2968.51%	-131.55%	-130.13%
Return on Assets (ROA)	-104.63%	-169.87%	-291.87%	-173.43%	-68.30%	-54.34%
Return on Capital Employed (ROCE)	183.10%	127.80%	267.90%	642.30%	-211.00%	-62.60%
Earnings Yield	-5.69%	-10.92%	-33.98%	-39.41%	-5.00%	-4.53%
FCF Yield	-3.82%	-4.21%	-19.16%	-22.87%	-5.04%	-2.17%
Buyback Yield / Dilution	-24.46%	-34.57%	-31.84%	-47.74%	-45.55%	-12.98%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q